Clinical Trial Update: Terlipressin Administration in Septic Shock Refractory to Catecholamines [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating terlipressin for septic shock refractory to catecholamines; current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Septic Shock | Phase 2 | Status: UNKNOWN